Molecular Pathology, Malmö
21 – 30 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
(
- Contribution to journal › Article
- 2014
-
Mark
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
(
- Contribution to journal › Article
-
Mark
The nuclear localization of γ-tubulin is regulated by SadB-mediated phosphorylation.
(
- Contribution to journal › Article
- 2013
-
Mark
Cell cycle deregulation in breast cancer subgroups and effects on proliferation, migration and tamoxifen resistance
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity
(
- Contribution to journal › Article
- 2012
-
Mark
Tumors with non-functional RB1 are killed by reduced gamma-tubulin levels.
(
- Contribution to journal › Article
- 2011
-
Mark
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
(
- Contribution to journal › Article
-
Mark
Nuclear localization of {gamma}-tubulin affects E2F transcriptional activity and S-phase progression.
(
- Contribution to journal › Article
- 2010
-
Mark
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
(
- Contribution to journal › Article
- 2009
-
Mark
SADB kinases license centrosome replication
(
- Contribution to journal › Debate/Note/Editorial